Supplies water treatment components, including membranes and related products, to industrial and municipal customers. The company distributes Hydranautics membranes, which currently account for about 6% of revenue, and holds inventory at a godown in Pune. A Rs. 2.34 Cr membrane supply order was disclosed for the Rayapuram CETP (Common Effluent Treatment Plant) wastewater project, and management has guided to approximately Rs. 3 Cr in export revenue for FY26, along with a 15–20% organic CAGR target over five years. A WhatsApp Chatbot is being launched to give global customers round-the-clock access to product details and catalogues. Operating costs are dominated by employee expenses (7.7% of revenue) and other operating expenses (3.8% of revenue), with materials shown at 0% of revenue and capex at 0.1%, consistent with a distribution-led model. Revenue from operations for FY26 was Rs. 97.6769 crore, up 12.4% year-on-year. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Water treatment components and related products, Hydranautics membrane distribution (6%). Small-cap water treatment component distribution, BSE SME-listed
| ₹ crore · consolidated | FY19 | FY21 | FY22 |
|---|---|---|---|
| Revenue | 54 | 58 | 75 |
| EBITDA (ex other income) | — | — | — |
| margin % | — | — | — |
| Owners' profit | — | — | — |
| EPS, as reported (₹) | 2.47 | 1.62 | 3.59 |
| ROE % · ROCE % | — · 24.4 | — · 13.7 | — · 24.3 |
| Debt / equity (x) | — | — | — |
| Cash from operations | — | 1 | 1 |
| Capex | — | — | — |
| ₹ crore | Q4 FY19 | Q2 FY20 | Q2 FY21 | Q4 FY21 | Q2 FY22 | Q4 FY22 |
|---|---|---|---|---|---|---|
| Revenue | 28 | 27 | 21 | 36 | 34 | 41 |
| Profit before tax | 2 | 1 | 1 | 1 | 2 | 3 |
| Net profit | — | — | — | — | — | — |
| EPS (₹) | 1.50 | 1.38 | 0.55 | 1.06 | 1.35 | 2.24 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 13.0 | 16.1 | 5 of 14 | 69% |
| ROCE | 23.9 | 15.4 | 3 of 16 | 87% |
| Revenue growth | 51.7 | 20.8 | 4 of 13 | 75% |
| Market cap | 74 | 807 | 15 of 16 | 7% |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 2 Sept 2026 · 15th AGM set for September 24; e-voting begins September 21 | compliance | minimal | — | — |
| 1 Sept 2026 · Filtra files FY26 Annual Report; 15th AGM on Sep 24, 2026 | board shareholder meetings | medium | — | — |
| 1 Sept 2026 · 15th AGM on September 24, 2026; director re-appointments on agenda | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Notice of 15th AGM on September 24, 2026 via video conferencing | compliance | minimal | — | — |
| 25 Aug 2026 · Filtra Consultants fixes Sep 17 record date for AGM and final dividend | corporate actions | high | — | — |
| 25 Aug 2026 · Record date Sept 17 for AGM and possible final dividend | corporate actions | medium | — | — |
| 25 Aug 2026 · Record date fixed at September 17, 2026 for 15th AGM and final dividend | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Board approves Directors Report, fixes 15th AGM for September 24, 2026 | board shareholder meetings | low | — | — |
| 17 Aug 2026 · Filtra Consultants appoints Ms. Seema C Kakade as Additional Independent Director | management changes | medium | — | — |
| 15 Jul 2026 · Compliance certificate under SEBI Regulation 74(5) for Q1 FY27 | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
